Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,530 | 10,254 | 11,394 | 3,869 | 4,817 |
| TOTAL | $9,501 | $10,681 | $12,053 | $4,693 | $5,245 |
| Non-Current Assets | |||||
| Intangibles | 6 | 7 | 7 | 7 | 7 |
| TOTAL | $6 | $7 | $7 | $7 | $7 |
| Total Assets | $9,507 | $10,687 | $12,060 | $4,699 | $5,252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 139 |
| Accounts payable and accrued liabilities | 777 | 627 | 329 | 100 | 184 |
| Accrued Expenses | N/A | N/A | N/A | 158 | N/A |
| TOTAL | $777 | $627 | $329 | $258 | $323 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $777 | $627 | $329 | $258 | $323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17 | 16 | 16 | 12 | 10 |
| Common Shares | 10 | 10 | 10 | 7 | 7 |
| Retained earnings | -18,568 | -16,852 | -14,718 | -12,035 | -10,766 |
| TOTAL | $8,730 | $10,061 | $11,731 | $4,441 | $4,929 |
| Total Liabilities And Equity | $9,507 | $10,687 | $12,060 | $4,699 | $5,252 |